Option Care Health (NASDAQ:OPCH) Stock Rating Lowered by Stephens

Option Care Health (NASDAQ:OPCH) was downgraded by investment analysts at Stephens from a “strong-buy” rating to a “hold” rating in a research note issued on Friday,Zacks.com reports.

OPCH has been the topic of a number of other reports. TD Cowen decreased their price objective on Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a report on Friday, May 1st. Barrington Research dropped their target price on Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Weiss Ratings cut shares of Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Morgan Stanley set a $28.00 price target on shares of Option Care Health in a research note on Wednesday, May 6th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $26.00 price target on shares of Option Care Health in a research report on Friday, May 1st. Eight analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $30.08.

Option Care Health Price Performance

NASDAQ OPCH opened at $21.74 on Friday. The stock has a market capitalization of $3.41 billion, a PE ratio of 16.85, a P/E/G ratio of 1.21 and a beta of 0.65. Option Care Health has a twelve month low of $18.01 and a twelve month high of $36.80. The stock has a 50-day simple moving average of $21.15 and a 200 day simple moving average of $27.50. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.07 and a current ratio of 1.64.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The company’s quarterly revenue was up 1.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.40 EPS. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Research analysts anticipate that Option Care Health will post 1.64 EPS for the current year.

Insider Activity at Option Care Health

In related news, CEO John Charles Rademacher purchased 12,500 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The stock was acquired at an average price of $21.18 per share, with a total value of $264,750.00. Following the completion of the purchase, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. This trade represents a 1.83% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,610 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were purchased at an average cost of $21.41 per share, with a total value of $783,820.10. Following the transaction, the director directly owned 450,000 shares of the company’s stock, valued at $9,634,500. This trade represents a 8.86% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased a total of 73,264 shares of company stock valued at $1,548,316 over the last quarter. 1.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of Option Care Health during the 4th quarter worth $61,787,000. Gamco Investors INC. ET AL grew its position in Option Care Health by 36.8% in the fourth quarter. Gamco Investors INC. ET AL now owns 369,002 shares of the company’s stock valued at $11,756,000 after acquiring an additional 99,244 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. acquired a new position in Option Care Health during the first quarter worth about $70,287,000. Leeward Investments LLC MA raised its stake in Option Care Health by 15.3% during the fourth quarter. Leeward Investments LLC MA now owns 488,416 shares of the company’s stock worth $15,561,000 after acquiring an additional 64,868 shares in the last quarter. Finally, SG Americas Securities LLC raised its stake in Option Care Health by 317.7% during the fourth quarter. SG Americas Securities LLC now owns 57,113 shares of the company’s stock worth $1,820,000 after acquiring an additional 43,441 shares in the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.